Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics.

Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A.

Sci Rep. 2013;3:1095. doi: 10.1038/srep01095. Epub 2013 Feb 5.

2.

STAT3-Ser/Hes3 Signaling: A New Molecular Component of the Neuroendocrine System?

Nikolakopoulou P, Poser SW, Masjkur J, Fernandez Rubin de Celis M, Toutouna L, Andoniadou CL, McKay RD, Chrousos G, Ehrhart-Bornstein M, Bornstein SR, Androutsellis-Theotokis A.

Horm Metab Res. 2016 Feb;48(2):77-82. doi: 10.1055/s-0041-111699. Epub 2016 Jan 19. Review.

PMID:
26783739
3.

The STAT3-Ser/Hes3 signaling axis in cancer.

Poser SW, Park DM, Androutsellis-Theotokis A.

Front Biosci (Landmark Ed). 2014 Jan 1;19:718-26. Review.

PMID:
24389215
4.

The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture.

Haley EM, Kim Y.

Cancer Lett. 2014 Apr 28;346(1):1-5. doi: 10.1016/j.canlet.2013.12.003. Epub 2013 Dec 11. Review.

5.

STAT3 as a Therapeutic Target for Glioblastoma.

Liu Y, Li C, Lin J.

Anticancer Agents Med Chem. 2010 Sep;10(7):512-9. Review.

PMID:
20879983
6.

Laboratory models for central nervous system tumor stem cell research.

Khan IS, Ehtesham M.

Adv Exp Med Biol. 2015;853:69-83. doi: 10.1007/978-3-319-16537-0_5. Review.

PMID:
25895708
7.

Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme.

Miska J, Lesniak MS.

EBioMedicine. 2015 Aug 14;2(8):774-5. doi: 10.1016/j.ebiom.2015.08.022. eCollection 2015 Aug. Review. No abstract available.

Supplemental Content

Support Center